Corrigendum to molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspective progress in retinal and eye research (2018) Vol 63,107-131

Affiliations

• ¹ School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil; Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA.
• ² Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, South Korea.
• ³ Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA.
• ⁴ Pharmaceutical Research and Development, Ezequiel Dias Foundation, Belo Horizonte, Brazil.
• ⁵ School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
• ⁶ Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA; Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, South Korea.
• ⁷ Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA; Department of Chemical Engineering and Materials Sciences, University of California, Irvine, CA, USA; Department of Biomedical Engineering, University of California, Irvine, CA, USA; Department of Molecular Biology and Biochemistry, University of California, Irvine, CA, USA. Electronic address: [email protected].